Headline
The latest stories from AHA Today.
The Department of Health and Human Services today announced the availability of $20 billion to hospital and providers through the third Provider Relief Fund general distribution.
The application period begins Oct. 5.
President Trump signed into law a continuing resolution that generally extends current federal funding levels for health care and other programs through Dec. 11, preventing a government shutdown as fiscal year 2020 funding expired.
The AHA Center for Health Innovation has launched the Living Learning Network, a peer-to-peer community where health care professionals can connect, share and learn.
The National Institutes of Health launched the IMPROVE (Implementing a Maternal Health and Pregnancy Outcomes Vision for Everyone) initiative, which seeks to improve maternal health outcomes and reduce disparities through research on the causes of maternal mortality and complications.
The Centers for Medicare & Medicaid Services launched a website on the rule requiring hospitals to disclose their negotiated rates.
The House Committee on Oversight and Reform launched a two-day hearing to examine pricing practices for some of the nation’s costliest drugs.
The House of Representatives passed by voice vote the AHA-supported Helping Medicaid Offer Maternity Services Act (H.R. 4996), as amended.
An experimental mRNA vaccine for the COVID-19 virus generated a strong immune response in older adults in a phase 1 clinical trial, who generally tolerated it well, the National Institutes of Health reports.
The National Institutes of Health has awarded nearly $234 million to improve COVID-19 testing for underserved and vulnerable populations, such as African Americans, American Indians/Alaskan Natives, Latinos/Latinas, Native Hawaiians, older adults, pregnant women and those who are homeless or…
The Federal Communications Commission’s Wireline Competition Bureau has extended to Dec. 31 the deadline for recipients of COVID-19 Telehealth Program funding to purchase and implement eligible telehealth devices and services to address the COVID-19 pandemic.